Currently miRNA has been considered as a potential anticancer drug, in a recent study (69), researchers investigated the effect of miR-449a/CCNB1 axis on osteosarcoma through bioinformatics analysis and in vitro cellular assays, demonstrating that investigated miR-449a can inhibit osteosarcoma growth. This evidence concerns the gene CCNB1 and osteosarcoma.